Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals (NQ: AGIO )

34.44 USD +0.57 (+1.68%)
Official Closing Price Updated: 4:00 PM EDT, Sep 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agios Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients
From GlobeNewswire News Releases
Agios Pharmaceuticals Enters Oversold Territory (AGIO)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
Andrew Hirsch to Depart Agios and Remain a Strategic Advisor through October 2020 
From GlobeNewswire News Releases
2 Mid-Cap Healthcare Stocks to Buy Now
These drugmakers are in the sweet spot to provide market-beating returns. 
Tags CDNA AGIO NSRGY
From Motley Fool
Agios to Present at the Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020
From GlobeNewswire News Releases
Interesting AGIO Put And Call Options For October 16th
Investors in Agios Pharmaceuticals Inc (AGIO) saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Notable Thursday Option Activity: TWLO, AGIO, UNFI
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Twilio Inc (TWLO), where a total volume of 15,153 contracts has been traded thus... 
Tags Stocks
From Market News Video
CStone Pharmaceuticals Reports Financial Results for the First Half of 2020
CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and precision medicines, today... 
From PR Newswire
Agios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020
From GlobeNewswire News Releases
Agios Pharmaceuticals Inc (AGIO) Q2 2020 Earnings Call Transcript
AGIO earnings call for the period ending June 30, 2020. 
Tags Market News AGIO
From Motley Fool
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ... 
Tags BIO ANIK TCDA
From Benzinga
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
Agios Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating
Agios Pharmaceuticals sees its Relative Strength Rating hit the 80-plus level. 
From Investor's Business Daily
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Although there were promising updates from some coronavirus vaccine makers, negative headlines plagued Novavax, Inc. and Moderna Inc., sending their stocks lower by 4.7% and 23%, respectively, for the... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured ... 
Tags BPMC AVXL MEDP
From Benzinga
Agios to Webcast Conference Call of Second Quarter 2020 Financial Results on July 30, 2020
From GlobeNewswire News Releases
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 137 companies set new 52-week highs. Key Facts: Microsoft(NASDAQ: MSFT)was the ... 
Tags FMS RGR TTD
From Benzinga
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MRK IBB BGNE
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday, 82 companies set new 52-week highs. Key Facts: The largest company by market cap to set a new 52-week high ... 
Tags PLUG HALO ATHE
From Benzinga
Chart of the Day: Agios Pharmaceuticals (AGIO)
Tags NASDAQ:AGIO
From StockNews.com
Stocks Showing Improving Market Leadership: Agios Pharmaceuticals Earns 83 RS Rating
A Relative Strength Rating upgrade for Agios Pharmaceuticals shows improving technical performance. 
From Investor's Business Daily
Agios to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on Tuesday, June 23, 2020
From GlobeNewswire News Releases
Royalty Pharma Pulls the Off Largest IPO of 2020
The initial public offering was for a pharmaceutical company that doesn't want to make or sell any drugs. 
Tags VRTX AGIO UNKNOWN
From Motley Fool
CRISPR Rally: The First Gene-Editing Drug Continues To Show Promise
Crispr Therapeutics and Vertex Pharmaceuticals stocks popped Friday after the biotech companies unveiled updated results for a gene-editing drug in blood-disease treatment. 
From Investor's Business Daily
The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Benzinga Pre/Market Outlook VRTX
From Benzinga
Agios and Royalty Pharma Announce $255 Million Purchase Agreement for IDHIFA® Royalty
From GlobeNewswire News Releases
Agios Announces Clinical Proof-of-Concept Has Been Established in Phase 1 Study of Mitapivat, First-in Class PKR Activator, in Sickle Cell Disease
From GlobeNewswire News Releases
Agios First-in Class PKR Activator Mitapivat Demonstrates Sustained Hemoglobin Responses in Non-transfusion-dependent α- and β-Thalassemia in Phase 2 Study
From GlobeNewswire News Releases
The Daily Biotech Pulse: Soleno Flunks Late-Stage Study, Sanofi Strikes Breast Cancer Partnership, NanoViricides Shortlists Coronavirus Treatment Candidates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ERYP NNVC IBB
From Benzinga
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.